Loading…
Loading…

| MRK | Merck & Co., Inc. | $127.52 | $315.0B |
| NVS | Novartis AG | $153.08 | $291.0B |
| NVO | Novo Nordisk A/S | $48.19 | $214.1B |
| GILD | Gilead Sciences, Inc. | $130.34 | $161.8B |
| PFE | Pfizer Inc. | $24.83 | $141.5B |
| DHR | Danaher Corporation | $179.14 | $126.8B |
| BMY | Bristol-Myers Squibb Company | $60.76 | $124.1B |
| SNY | Sanofi | $43.79 | $105.3B |
| GSK | GSK plc | $50.76 | $101.7B |
| BSX | Boston Scientific Corporation | $42.97 | $63.9B |